- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01794052
To Develop a High Quality Health Care Delivery Model for the Management of Hypertension and Diabetes at CHCs and District Hospitals of Himachal Pradesh. (m-Power Heart)
August 5, 2016 updated by: Dr. Dorairaj Prabhakaran, Centre for Chronic Disease Control, India
m-Power Heart Project
Hypertension and diabetes are major risk factors for cardiovascular diseases.
Although these two conditions can be detected much early in life and are amenable to interventions at primary health care level, the health system in India fails to provide adequate interventions at primary health care level which translates to huge burden of undiagnosed and uncontrolled hypertension and diabetes in the community.
This study aims to design a feasible and sustainable evidence-based, decision support-enabled, health care delivery model for the management of hypertension and diabetes in the primary health care facilities of Himachal Pradesh.
The study will be conducted at the 5 Community Health Centers (CHCs) and District Hospital of Solan District, Himachal Pradesh using both qualitative and quantitative methods.
The design and development of the model will be carried out in the initial six months followed by piloting the services at the CHCs and District Hospital.
The impact of the model on quality of care will be assessed in a pre-post design measuring changes in both clinical and process indicators.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aims to design a feasible and sustainable evidence-based, decision support-enabled, health care delivery model for the management of hypertension and diabetes in the primary health care facilities of Himachal Pradesh.
The study will be conducted at the 5 Community Health Centers (CHCs) and District Hospital of Solan District, Himachal Pradesh using both qualitative and quantitative methods.
The design and development of the model will be carried out in the initial six months followed by piloting the services at the CHCs and District Hospital.
The impact of the model on quality of care will be assessed in a pre-post design measuring changes in both clinical and process indicators.
Study Type
Interventional
Enrollment (Actual)
6797
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Himachal Pradesh
-
Solan, Himachal Pradesh, India, 173212
- CHCs and District Hospital of Solan District
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All consenting adults of age >30 years attending the Community Health Centre's and Civil Hospital of Solan District of Himachal Pradesh.
Exclusion Criteria:
- Person not willing to consent
- <30 years of age
- History of coronary heart disease or stroke
- Pregnant OR trying to become pregnant OR of child-bearing potential and not actively practicing birth control (including natural methods)
- Malignancy or life-threatening diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DSS enabled health care delivery model
Evidence based, DSS enabled, health care delivery model
|
The study focus on preliminary work before a definitive randomised controlled trial. In this phase, we are developing an intervention for the evidence based management of hypertension and diabetes at primary care setting in India. The components of the interventions that we are developing are:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in the proportion of people with hypertension and/or diabetes receiving evidence based clinical management.
Time Frame: 30 months
|
30 months
|
Change in compliance to therapy and follow-up rate among people with hypertension and/or diabetes.
Time Frame: 30 months
|
30 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Dorairaj Prabhakaran, MD, DM, MSc, FRCP, Centre for Chronic Disease Control
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
August 1, 2014
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
January 23, 2013
First Submitted That Met QC Criteria
February 15, 2013
First Posted (Estimate)
February 18, 2013
Study Record Updates
Last Update Posted (Estimate)
August 8, 2016
Last Update Submitted That Met QC Criteria
August 5, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCDC-2013/001
- CTRI/2013/02/003412 (Registry Identifier: Clinical Trials Registry India)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Evidence based, DSS enabled, health care delivery model
-
Mayo ClinicCompletedSmoking CessationUnited States
-
Santa Clara Valley Health & Hospital SystemCompleted
-
Region ÖstergötlandRegion Jönköping County; Region Örebro CountyRecruitingBehavioral Symptoms | Primary Health Care | Mental DisorderSweden
-
Brigham and Women's HospitalRecruitingHypertensionSouth Africa
-
Yuzuncu Yıl UniversityAtaturk UniversityCompletedType2 Diabetes MellitusTurkey
-
Istanbul University - Cerrahpasa (IUC)RecruitingPreeclampsia | Healthy Lifestyle | Pregnancy; Renal DiseaseTurkey
-
Kastamonu UniversityEge UniversityNot yet recruiting
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); Gilead Sciences and other collaboratorsCompletedHypertension | Diabetes | HIV | Tuberculosis | Cost Effectiveness | Maternal Child HealthKenya, Uganda